Search Results - "Barker, Patricia J"
-
1
Intrapulmonary administration of recombinant activated factor VII in pediatric, adolescent, and young adult oncology and hematopoietic cell transplant patients with pulmonary hemorrhage
Published in Frontiers in oncology (2024)“…Diffuse alveolar hemorrhage (DAH) is a devastating disease process with 50-100% mortality in oncology and hematopoietic cell transplant (HCT) recipients. High…”
Get full text
Journal Article -
2
Predicting success of desensitization after pegaspargase allergy
Published in Blood (02-01-2020)Get full text
Journal Article -
3
Blinatumomab infusion interruptions in pediatric patients rarely lead to readmission
Published in Pediatric blood & cancer (01-10-2024)“…Blinatumomab is a bispecific T‐cell engager administered as a 28‐day continuous infusion. Infusions can be associated with interruptions requiring support from…”
Get full text
Journal Article -
4
Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease
Published in Pediatrics (Evanston) (01-07-2016)“…After postoperative deaths in children who were prescribed codeine, several pediatric hospitals have removed it from their formularies. These deaths were…”
Get full text
Journal Article -
5
Metabolic Acidosis in a Pediatric Patient with Leukemia and Fungal Infection
Published in Clinical chemistry (Baltimore, Md.) (01-04-2020)Get full text
Journal Article -
6
Limited sampling strategies for accurate determination of extended half‐life factor VIII pharmacokinetics in severe haemophilia A patients
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-05-2021)“…Background Extended half‐life (EHL) factor VIII (FVIII) products may decrease the burden of prophylactic treatment in haemophilia A by reducing infusion…”
Get full text
Journal Article -
7
Sulfamethoxazole-Trimethoprim Prophylaxis in Pediatric Oncology Patients With Glucose-6-Phosphate Dehydrogenase Deficiency
Published in The Pediatric infectious disease journal (07-08-2024)“…We sought to determine whether Pneumocystis jirovecii pneumonia prophylaxis with sulfamethoxazole-trimethoprim (SMX-TMP) is associated with an increased…”
Get full text
Journal Article